Fill-Finish Podcast
Stagione 1
Evolving Trends in Aseptic Processing
Global Supply Chain Management and Capacity Planning
The Past, Present, and Future of Advanced Aseptic Facility Design
di Rizwan Chaudhrey
With Industry media professional, Rizwan Chaudhrey, as host, the Fill-Finish Podcast shares expertise on all aspects of injectables, vaccines, and aseptic fill-finish. Season 1 features podcasts focused on facility design, quality, supply chain management, global health to name a few. Fill-Finish is sponsored by ApiJect.
COVID-19 has shown that pharma companies need to make their complex and inefficient global supply chains more resilient. With high-value therapeutics at stake, having a flexible, resilient, and robust manufacturing supply chain is more important than ever. Learn more about ensuring capacity, meeting global demand, and what we can expect in regard to outsourced manufacturing and the ever-evolving changes in the pharmaceutical supply chain. Join industry expert, Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals, to learn more.
STERLING "It was way back when in 1978 that we started with aseptic processing. That was really at the beginning of the technology throughout the industry, and it has evolved over the past two generations. In the very beginning, we were all learning and so typically, from an architectural standpoint, we were building facilities that look like any other facility in the world and we really did not understand the technology of clean rooms and the technology involved with that. Both from an architectural standpoint and buildings, mechanical, the whole building process, but then also from an equipment side, and all of that has evolved." JASON "In the early 2000s, we saw some things happening, which really created some chaos, but also gave us some direction. We had some new guidance coming out from the FDA, I believe in 2004, they had their newer guidance for industry for sterile facilities. Surely before that I think a year before that the European Commission also issued their version of sterile guidelines in their Annex One documentation. So now all of a sudden, you're getting some direction. You're getting some guidance. You're not being told exactly what to do, because it's guidance, but now all of a sudden there's something to follow. So the big challenge at that time was you had you know hundreds or probably thousands of manufacturing facilities around the world that now we're in a state of assessing where are we with this guidance. Are we in compliance? Are we out of compliance? How long are they going to allow us to operate the way we are operating? And I think they were starting to get some feedback from the auditors and inspectors saying hey you really need to be moving in this new direction, we're smarter now, the science is better. We know where we have issues, and you should be starting to address those for better products and better patient safety."life science industry? Download Transcript Here 1. (03:05) Sterling, what was the state of aseptic processing when you started in the life science industry? 2. (13:34) Jason, when did you join the industry and where was the focus for aseptic processing at that time? 3. (18:20) What does aseptic processing look like today? What are the challenges now? 4. (24:35) Where are we going? What does the future look like?
The Fill-Finish podcast launches with its first episode, featuring Les Edwards from SKAN US, discussing the topic of "Current Trends in Isolation Technology and Vaccine Production" with host, Rizwan Chaudhrey.